Pharma Equity Group A/S: Financial statements 2023
CVR: 26791413
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK -24,609,000 compared with DKK 3,479,000 the year before. Equity in the 2023 report amounted to DKK 38,931,000. The solvency ratio was 47.9%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -24,609,000
- Equity
- DKK 38,931,000
- Total Assets
- DKK 81,335,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | 0 | -24.6 mio. | 38.9 mio. | - |
| 2022 | - | - | 3.5 mio. | 46 mio. | - |
| 2021 | - | - | 5.4 mio. | 42.6 mio. | - |
| 2020 | - | - | -32.9 mio. | 34.3 mio. | - |
| 2019 | - | - | -14.4 mio. | 67.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharma Equity Group A/S has published its interim report for the period January 1, 2023 – September 30, 2023.
As of November 2, 2023, Martin Engell-Rossen has joined the board of directors of Pharma Equity Group A/S.
As of November 2, 2023, Omar Siraj M Qandeel has joined the board of directors of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2023 – June 30, 2023.
As of June 15, 2023, Christian Vinding Thomsen has joined the board of directors of Pharma Equity Group A/S.
As of June 15, 2023, Peter Mørch Eriksen has left the board of directors of Pharma Equity Group A/S.
As of June 15, 2023, Ole Larsen has left the board of directors of Pharma Equity Group A/S.
As of June 14, 2023, Christian Vinding Thomsen has left the board of directors of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2023 – March 31, 2023.
Pharma Equity Group A/S has published its annual report for 2022. The net result was DKK 3,479,000.
About Pharma Equity Group A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.